Hans-Georg Sahl

Research.com Recognitions

• 2023 - Research.com Biology and Biochemistry in Germany Leader Award

Overview

Best Publications

• Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.

  Robert E W Hancock;Hans-Georg Sahl

  4833
  Citations

• Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature

  Paul G. Arnison;Mervyn J. Bibb;Gabriele Bierbaum;Albert Alexander Bowers

  2194
  Citations

• The co-evolution of host cationic antimicrobial peptides and microbial resistance

  Andreas Peschel;Hans-Georg Sahl

  1278
  Citations

• Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic

  E. Breukink;I. Wiedemann;C. van Kraaij;O. P. Kuipers

  1057
  Citations

• Insights into the Mode of Action of Chitosan as an Antibacterial Compound

  Dina Raafat;Kristine von Bargen;Albert Haas;Hans-Georg Sahl

  1008
  Citations

• Chitosan and its antimicrobial potential – a critical literature survey

  Dina Raafat;Hans-Georg Sahl

  956
  Citations

• Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity

  Wiedemann;E Breukink;C van Kraaij;Oscar Kuipers

  952
  Citations

• New developments in RiPP discovery, enzymology and engineering

  Manuel Montalbán-López;Thomas A Scott;Sangeetha Ramesh;Imran R Rahman

  735
  Citations

• Lantibiotics: Mode of Action, Biosynthesis and Bioengineering

  G. Bierbaum;H.-G. Sahl

  652
  Citations

• Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria.

  Hans-Georg Sahl;Gabriele Bierbaum

  647
  Citations

• Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II

  Tanja Schneider;Thomas Kruse;Reinhard Wimmer;Imke Wiedemann

  567
  Citations

• Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Fast and Reliable Identification of Clinical Yeast Isolates

  G. Marklein;M. Josten;U. Klanke;E. Müller

  555
  Citations

• Dysregulation of bacterial proteolytic machinery by a new class of antibiotics

  Heike Brötz-Oesterhelt;Dieter Beyer;Hein-Peter Kroll;Rainer Endermann

  547
  Citations

• Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics.

  Heike Brötz;Michaele Josten;Imke Wiedemann;Ursula Schneider

  529
  Citations

• The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II

  Heike Brötz;Gabriele Bierbaum;Klaus Leopold;Peter E. Reynolds

  525
  Citations

• Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles

  E Ruhr;H G Sahl

  494
  Citations

• Biosynthesis and Biological Activities of Lantibiotics with Unique Post-Translational Modifications

  Hans-Georg Sahl;Ralph W. Jack;Gabriele Bierbaum

  473
  Citations

• Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding

  Tiffanny Jones;Michael R. Yeaman;Michael R. Yeaman;Michael R. Yeaman;George Sakoulas;Soo-Jin Yang

  460
  Citations

• Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria

  Yann Héchard;Hans Georg Sahl

  442
  Citations

• Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains

  Anna Müller;Michaela Wenzel;Henrik Strahl;Fabian Grein

  399
  Citations